Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T36620 |
ALK4290
ALK4290 |
||
ALK4290 (AKST4290) is a potent and orally actively CCR3 inhibitor, compound Example 2, with a Ki of 3.2 nM for hCCR3[1]. ALK4290 can be used for the research of neovascular age-related macular degeneration and Parkinsonism[2][3]. |